The Future of Sleep Apnea Therapy
This presentation is the property of its rightful owner.
Sponsored Links
1 / 57

The Future of Sleep Apnea Therapy Atul Malhotra, MD ([email protected]) PowerPoint PPT Presentation


  • 55 Views
  • Uploaded on
  • Presentation posted in: General

The Future of Sleep Apnea Therapy Atul Malhotra, MD ([email protected]) Associate Professor of Medicine Medical Director, Sleep Program Clinical Chief, Sleep Division BWH and SHC Harvard Medical School NESS 2010. Inadequate Anatomy Compensatory Reflex  Activity of

Download Presentation

The Future of Sleep Apnea Therapy Atul Malhotra, MD ([email protected])

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

The Future of Sleep Apnea Therapy

Atul Malhotra, MD

([email protected])

Associate Professor of Medicine

Medical Director, Sleep Program

Clinical Chief, Sleep Division

BWH and SHC

Harvard Medical School

NESS 2010


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Inadequate Anatomy

Compensatory

Reflex

Activity of

Pharyngeal Dilators

(GG)

Sleep Fragmentation

Neurocognitive

Sequelae

Airway

Collapse

Endothelin

Vagus

Cardiovascular

Sequelae

Maintains Upper

Airway Patency

Sympathetic

Activation

Sleep Onset

Arousal

Loss of

Reflex

Respiratory

Effort

Activity of

Pharyngeal Dilators

Hypoxia + Hypercapnia

Malhotra and White

Lancet 2002


Current standard therapy is cpap

Current Standard Therapy is CPAP

  • Treatment of choice meta-analysis, SLEEP 2003

  • Improves symptoms and blood pressure

  • Adherence is variable


Alternative therapies

Alternative Therapies

  • Bi-level – no convincing data

  • APAP – Patel et al. SLEEP 2004

  • Cflex – Aloia et al. Chest 2005

  • CRT in CHF – Stanchina et al. Chest 2007

  • Oral appliances – variable response, limited data

  • Surgery – poor efficacy, minimal ability to predict who will respond


Osa pathogenesis

OSA Pathogenesis

Patients do not all get OSA for the same reason.

There are likely to be multiple mechanistic pathways and we need to recognize and target them.

Owens et al. SLEEP 2009; Saboisky Thorax 2010


Obstructive sleep apnea underlying mechanisms

Obstructive Sleep Apnea Underlying Mechanisms

  • Anatomy

  • Pharyngeal dilator muscle control asleep

  • Arousal Threshold

  • Loop gain

  • Lung volume

  • Vascular


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Pharyngeal anatomy explains only a minimal portion of the variability in AHI


Finite element modeling

Finite Element Modeling

  • 1. Upper airway mechanics: influence of gender

    IEEE 2002

  • 2. A pressure and state-dependent muscle contraction model and its application in the computational simulation of human upper airway collapseJAP 2005

  • 3. Mandibular advancement and UPPP effects on pharyngeal mechanics based on FEAIEEE 2003

  • 4. The impact of anatomical manipulation on pharyngeal mechanics: results from a computational model, Chest 2005

  • 5. Invididualizing Therapy

    Laryngoscope 2007


Finite element modeling1

Finite Element Modeling

  • Signal average MRI

  • Muscle contracts per experimental data

  • Tissue elastic modulus derived from back calculations from the literature

  • Allows tissue displacement and air-solid interactions

  • Measure Pcrit as primary outcome variable


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Mandibular Advancement

A 1-cm mandibular advancement has a substantial impact on collapsibility:P close = -21 cmH2O with; -13 cmH2O without mandibular advancement

Huang, White and Malhotra, Chest 2005


Uvula removal

Huang, White and Malhotra Chest 2005

Uvula Removal

Uvula removal can have a substantial effect on collapsibility:P close = -18 cmH2O with uvula removal; -13 cmH2O with intact uvula.


Comparison of different uppp treatments

Comparison of Different UPPP Treatments

3

2

1


Airway length

Airway Length

  • Normal men have longer airway than women (Malhotra et al. AJRCCM 2002)

  • Boys develop longer airway at puberty as compared with girls (Ronen et al., Pediatrics 2007)

  • Women experience airway lengthening at menopause (Malhotra et al. AJM 2006)

  • OSA patients also have gender differences in some data sets (Pillar et al., S & B 2008)

  • Modeling shows that length affects mechanics

  • Airway length may explain considerable variance in airway mechanics and components of various epidemiological risk factors


Is blinding possible

Is Blinding Possible?


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

A double blind Imaging Study


Construction of 3d structure using multiple mr images

Construction of 3D Structure Using Multiple MR Images


Comparison of regions b c

Comparison of Regions b & c


Science fiction

Science Fiction?

  • Can we individualize therapy based on imaging?

  • Our imaging collaborators do intraoperative MRI during craniotomy to simulate brain deformation following tumor resection

  • Neurosurgeons are now using this in real time to determine the extent of tumor resection

  • Requirement that individual anatomy can be down-loaded into the FEA model


Obstructive sleep apnea underlying mechanisms1

Obstructive Sleep Apnea Underlying Mechanisms

  • Anatomy

  • Pharyngeal dilator muscle control asleep

  • Arousal Threshold

  • Loop gain

  • Lung volume

  • Vascular


Richard schwab clinics in chest medicine 1998

Richard SchwabClinics in Chest Medicine, 1998


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

JCI 1991


Pharyngeal motor control studies

Pharyngeal Motor Control Studies

  • 1. Genioglossal But Not Palatal Muscle Activity Relates Closely to Pharyngeal Pressure Malhotra et al. AJRCCM 2000a,2000b AJRCCM 2002

  • 2. Within-breath control of genioglossal muscle activation in humans: effect of sleep-wake stateJ. Physiol. 2003

  • 3. Control of upper airway muscle activity in younger vs older men during sleep onsetJ. Physiol. 2004

  • 4. The impact of wakefulness stimulus on pharyngeal motor control Lo et al Thorax 2007

  • 5. Mechanisms of Compensation

    Jordan et al Thorax 2007, Sleep 2009


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Stanchina et al.


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Malhotra et al. AJM 2006

R=-0.55, p<0.001


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

J Physiol 2007


Single motor units and sfemg

Single Motor Units and SFEMG

  • Wilkinson et al. SLEEP 2008

  • Saboisky et al. J Physiol. 2007

  • Saboisky et al. J Neurophysiol. 2006

  • Wilkinson et al. SLEEP 2010

  • High frequency sampling of EMGs

  • Can “see” activity of single cells in humans

  • Has opened possibility of pharmacological targets


Pharyngeal muscle control

Pharyngeal Muscle Control

  • There are likely to be subgroups of patients who respond to efforts to augment muscle activation

  • Perhaps targeting this subgroup would make sense in pharmacological studies (JAP 2008)

  • Increasing upper airway muscle responsiveness may be deleterious in patients with unstable ventilatory control


Obstructive sleep apnea underlying mechanisms2

Obstructive Sleep Apnea Underlying Mechanisms

  • Anatomy

  • Pharyngeal dilator muscle control asleep

  • Arousal Threshold

  • Loop gain

  • Lung volume


Berry et al ajrccm 1997

Berry et al – AJRCCM, 1997


Gleeson et al 1990 am rev respir dis

Gleeson et al – 1990 Am Rev Respir Dis


Arousal threshold double edged sword

Arousal Threshold – Double-edged Sword

  • A low arousal threshold could lead to premature arousal with inadequate time to accumulate respiratory stimuli (CO2 and neg pressure)

  • A high arousal threshold could lead to substantial hypoxemia and hypercapnia with end-organ impact

  • Therapies to manipulate arousal threshold are likely to benefit some patients and theoretically hurt others

Saboisky et al. Thorax 2010


Arousal threshold

Arousal Threshold

  • Agents that increase arousal threshold e.g. sedatives can prevent state instabilityYounes et al SLEEP 2007

    Park et al SLEEP 2008

  • Certain patients who arouse easily may be more amenable to these than others

  • Ideally the agent does not suppress UA muscle activity

  • Delaying arousal may allow time for UA muscles to ↑

  • Most OSA patients have some periods of stable breathing

  • UA muscles are necessary and sufficient to stabilize breathing (SLEEP 2009)


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

  • Most OSA patients have spontaneous periods of breathing stability

  • Studied GGEMG, TPEMG, EELV etc

Sleep 2009


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

ERJ 2008


Pharmacology studies of sedation anesthesia in rats

Pharmacology Studies of Sedation/Anesthesia in Rats

  • Unwarranted Administration of Acetylcholinesterase Inhibitors Can Impair Genioglossus and Diaphragm Muscle Function. Anesthesiology 2007

  • Differential effects of isoflurane and propofol on genioglossus muscle function and breathing. Anesthesiology 2008

  • Sugammadex Brit J. Anesth. 2008

  • Pentobarbital Anesthesiology 2009

  • Rocuronium vs. Cisatracurium AJCC 2009

  • Pentobarbital in humans ERJ in press

  • Agents have differential effects on the upper airway

Chamberlin et al.


Obstructive sleep apnea underlying mechanisms3

Obstructive Sleep Apnea Underlying Mechanisms

  • Anatomy

  • Pharyngeal dilator muscle control asleep

  • Arousal Threshold

  • Loop gain

  • Lung Volume

  • Vascular function


Loop gain

Loop Gain

  • measure of the stability of negative feedback control system

    Younes AJRCCM 2001

    Wellman et al JAP 2003

    Wellman et al AJRCCM 2004

    Wellman et al J Physiol 2007

    Wellman et al. Resp Physiol 2008Jordan et al J Physiol 2004

    Jordan et al JAP 2006


Thermostat analogy

Thermostat Analogy


Cheyne stokes respirations

Cheyne Stokes Respirations


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

r = 0.36

p = 0.076


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

r = 0.88

p = 0.0016

AJRCCM 2004


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Change in Ventilatory Effort Across an Obstructive Apnea

PN

E2

E1

ABD

Effort Index = (E2 – E1) / E2


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Effort Index may be a Reasonable Surrogate for Loop Gain

1

R = 0.96

0.8

P < 0.05

Effort

Index

0.6

0.4

0.2

0

0

0.2

0.4

0.6

0.8

1

1.2

Loop Gain


Obstructive sleep apnea future treatment

Obstructive Sleep ApneaFuture Treatment

  • Define the apnea mechanism and treat accordingly.


Obstructive sleep apnea underlying mechanisms4

Obstructive Sleep ApneaUnderlying Mechanisms

High Loop Gain

Administer agents to reduce loop gain:

  • Oxygen

  • Acetazolamide


Effect of oxygen between groups

Effect of Oxygen Between Groups

100

80

p = 0.016

60

40

%

Reduction

in AHI

20

0

-20

-280

Resp Physiol 2008

High Loop

Gain

Low Loop

Gain


The future of sleep apnea therapy atul malhotra md amalhotra1 partners

Malhotra and White Lancet 2002


Lung volume story

Lung Volume Story

  • EELV can alter pharyngeal mechanics

  • Van De Graaf JAP

  • Mechanisms debated

  • Prior studies during wakefulness are seriously confounded

  • Stanchina et al. SLEEP 2003

  • Heinzer et al. AJRCCM 2005

  • Heinzer et al. Thorax 2006

  • Heinzer et al. Sleep 2008

  • Owens et al. JAP in press


Non cpap therapies for osa

Non CPAP therapies for OSA

  • 1. Oxygen

  • 2. Lung volume augmentation

  • 3. sedatives

  • 4. Pressure relief strategies

  • 5. Tailored therapy e.g. UPPP

  • 6. Neuropharmacology

  • 7. Block vascular complications


Disclosures funding

Disclosures /Funding

Grants PI: Malhotra

  • NHLBI RO1 HL 073146 cardiovascular

  • NHLBI RO1 HL 085188 electrophysiology

  • NHLBI RO1 HL 090897 aging airway mechanics

  • NHLBI K24 HL 093218 mentoring award

  • NHLBI PPG Project 2 (Overall PI Saper)

  • AHA Established Investigator Award 0840159N

    Industry

  • SepracorPfizer

  • MedtronicPhilips

  • MerckNMT Medical

  • Apnex Medical Itamar Medical

  • CephalonEthicon/J&J

  • SHCSGS


  • Login